COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection.

ABSTRACT: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and may result in an overactive coagulative system, thereby resulting in serious cardiovascular consequences in critically affected patients. The respiratory tract is a primary target for COVID-19 infection, which is manifested as acute lung injury in the most severe form of the viral infection, leading to respiratory failure. A proportion of infected patients may progress to serious systemic disease including dysfunction of multiple organs, acute respiratory distress syndrome (ARDS), and coagulation abnormalities, all of which are associated with increased mortality, additionally depending on age and compromised immunity. Coagulation abnormalities associated with COVID-19 mimi

SUBMITTER: Sharma S 

PROVIDER: S-EPMC8913175 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature